Brigit Biofarmaka Teknologi Tbk.

OBAT · Kesehatan · Farmasi & Riset Kesehatan

242

-46.7% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 38

  • Value

    53Against 788 other IDX companies

    Priced about in line with comparable stocks.

    P/E
    12.5×
    62%Cheaper than 62% of other IDX companies
    P/B
    1.2×
    49%Cheaper than 49% of other IDX companies
    Dividend yield
    3.1%
    48%Higher than 48% of other IDX companies
  • Quality

    71Against 788 other IDX companies

    More profitable than most comparable stocks.

    Return on equity
    8.9%
    63%Higher than 63% of other IDX companies
    Return on assets
    9.7%
    84%Higher than 84% of other IDX companies
    Net margin
    9.3%
    65%Higher than 65% of other IDX companies
  • Growth

    34Against 788 other IDX companies

    Growing slower than most comparable stocks.

    Profit, last 4 quarters
    -64.7%
    15%Higher than 15% of other IDX companies
    Profit, 3-year yearly
    +22.3%
    72%Higher than 72% of other IDX companies
    Profit, latest quarter vs a year ago
    -60.3%
    26%Higher than 26% of other IDX companies
    Revenue, latest quarter vs a year ago
    -5%
    24%Higher than 24% of other IDX companies
  • Momentum

    14Against 836 traded stocks

    Has lagged most stocks over the past year.

    1-year price change
    -51.4%
    14%Better than 14% of traded stocks
  • Liquidity

    20Against 836 traded stocks

    Thinly traded compared with most IDX stocks.

    Value traded per day, 30 days
    IDR 132M
    20%Higher than 20% of traded stocks
  • Retail penalty

    −0Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 1% of the other stocks where it is, so 0 points come off the rating.

    Retail average buy
    243
    Close vs that average
    -0.4%
    Retail net bought
    -15K lots

Similar stocks

Rated most like OBAT across the five pillars. Change is over the past year.